These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population. Gutiérrez-Castañeda LD; Gamboa M; Nova JA; Pulido L; Tovar-Parra JD Biomed Res Int; 2020; 2020():2046947. PubMed ID: 32775409 [TBL] [Abstract][Full Text] [Related]
6. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma. García-Casado Z; Traves V; Bañuls J; Niveiro M; Gimeno-Carpio E; Jimenez-Sanchez AI; Moragón M; Onrubia JA; Oliver V; Kumar R; Nagore E Br J Dermatol; 2015 Apr; 172(4):1128-31. PubMed ID: 25385688 [No Abstract] [Full Text] [Related]
7. Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population. Evrenos MK; Temiz P; Çam FS; Yaman M; Yoleri L; Ermertcan AT Turk J Med Sci; 2018 Oct; 48(5):973-979. PubMed ID: 30384563 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma. Moltara ME; Novakovic S; Boc M; Bucic M; Rebersek M; Zadnik V; Ocvirk J Radiol Oncol; 2018 Apr; 52(3):289-295. PubMed ID: 30210039 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma. Barel F; Guibourg B; Lambros L; Le Flahec G; Marcorelles P; Uguen A Acta Derm Venereol; 2018 Jan; 98(1):44-49. PubMed ID: 28660280 [TBL] [Abstract][Full Text] [Related]
10. The molecular profile of metastatic melanoma in Australia. Lyle M; Haydu LE; Menzies AM; Thompson JF; Saw RP; Spillane AJ; Kefford RF; Mann GJ; Cooper WA; Yu B; Scolyer RA; O'Toole SA; Long GV Pathology; 2016 Feb; 48(2):188-93. PubMed ID: 27020391 [TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma. Sheen YS; Chu CY Br J Dermatol; 2021 Mar; 184(3):390-391. PubMed ID: 33448329 [No Abstract] [Full Text] [Related]
12. Prevalence of BRAF and NRAS mutations in fast-growing melanomas. Nagore E; Hacker E; Martorell-Calatayud A; Traves V; Guillen C; Hayward NK; Whiteman D Pigment Cell Melanoma Res; 2013 May; 26(3):429-31. PubMed ID: 23448684 [No Abstract] [Full Text] [Related]
13. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Yang S; Leone DA; Biswas A; Deng A; Jukic D; Singh R; Sundram U; Mahalingam M Hum Pathol; 2018 Dec; 82():206-214. PubMed ID: 30120967 [TBL] [Abstract][Full Text] [Related]
14. Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases. Pellegrini C; Cardelli L; Padova M; Nardo LD; Ciciarelli V; Rocco T; Cipolloni G; Clementi M; Cortellini A; Ventura A; Leocata P; Fargnoli MC Acta Derm Venereol; 2020 Jan; 100(1):adv00040. PubMed ID: 31774543 [TBL] [Abstract][Full Text] [Related]
15. Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue-white veil. Gouillon L; Perier-Muzet M; Amini-Adle M; Poulalhon N; Debarbieux S; Boespflug A; Balme B; Depaepe L; Harou O; Lopez J; Bringuier PP; Ferraro-Peyret C; Maucort-Boulch D; Robinson P; Thomas L; Dalle S J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e57-e59. PubMed ID: 31442328 [No Abstract] [Full Text] [Related]
16. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232 [TBL] [Abstract][Full Text] [Related]
17. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients. Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841 [TBL] [Abstract][Full Text] [Related]
18. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation]. Lázár V Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354 [TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma. Pracht M; Mogha A; Lespagnol A; Fautrel A; Mouchet N; Le Gall F; Paumier V; Lefeuvre-Plesse C; Rioux-Leclerc N; Mosser J; Oger E; Adamski H; Galibert MD; Lesimple T J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1530-8. PubMed ID: 25623140 [TBL] [Abstract][Full Text] [Related]
20. Concordance of somatic mutational profile in multiple primary melanomas. Adler NR; McLean CA; Wolfe R; Kelly JW; McArthur GA; Haydon A; Tra T; Cummings N; Mar VJ Pigment Cell Melanoma Res; 2018 Sep; 31(5):592-603. PubMed ID: 29603877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]